News tagged with tumor suppression

Study reveals trigger that may speed melanoma growth

(HealthDay) -- Growth of the deadly skin cancer melanoma may be triggered by the immune system turning on itself, according to a new study that also identified the mechanism that causes this to happen.

Mar 28, 2012
popularity 5 / 5 (3) | comments 0 | with audio podcast

Cometriq approved for rare thyroid cancer

(HealthDay)—Cometriq (cabozantinib) has been approved by the U.S. Food and Drug Administration to treat modullary thyroid cancer that has spread to other parts of the body, the agency said Thursday.

Nov 29, 2012
popularity 5 / 5 (1) | comments 0

Clinical trial targets advanced prostate cancer

Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.

Dec 03, 2012
popularity 5 / 5 (1) | comments 0